Clinical Trials Logo

Hyperlipidemia clinical trials

View clinical trials related to Hyperlipidemia.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04642742 Enrolling by invitation - Hyperlipidemia Clinical Trials

Impact of a Chewable Plant Sterol Supplement on LDL-C in A Real-World Setting

Start date: November 25, 2020
Phase:
Study type: Observational

The purpose of this study is to measure the effectiveness of a twice daily plant sterol supplement, which is in a gummy format and packaged with health insights, in reducing LDL-C cholesterol in a real word setting.

NCT ID: NCT04201314 Enrolling by invitation - Hyperlipidemia Clinical Trials

Effect of InnoSlim® on Blood Sugar and Blood Lipids Regulation in Humans

Start date: November 8, 2019
Phase: N/A
Study type: Interventional

InnoSlim® has been studied for enhancing metabolic functions whereas many lab studies have demonstrated the potential efficacy of InnoSlim® for the blood sugar and blood lipids regulation. There has been no relevant human study on InnoSlim® on blood sugar and blood lipids regulation. There have reported that 2018 estimating the total costs of diagnosed diabetes have risen to $327 billion in 2017 from $245 billion in 2012. Although pharmacological methods have been developed to treat diabetes, these treatments can be costly and are not without potential adverse effects. The development of dietary agents for the prevention of diabetes could represent a cost-effective and safe means to deal with this growing public health crisis.

NCT ID: NCT03639480 Enrolling by invitation - Hypertension Clinical Trials

Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

Start date: October 13, 2017
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of CJ-30061 compared with amlodipine/valsartan combination therapy and valsartan/atorvastatin combination therapy in hypertensive patients with hyperlipidemia

NCT ID: NCT02147041 Enrolling by invitation - Diabetes Mellitus Clinical Trials

The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides

Start date: May 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this study is to examine the therapeutic effect of green tea extract on obese women and the correlation analysis between traditional Chinese medicine syndrome and obese related hormone peptides.